HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q3 2020 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO) Q3 2020 Results Earnings Conference Call November 02, 2020, 04:30 PM ET Company Participants Al Kildani - Vice President-Investor Relations and Corporate Communications Helen Torley - President and Chief Executive Officer Elaine Sun - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Jim Birchenough - Wells Fargo Do Kim - BMO Capital Markets Jason Butler - JMP Securities Joe Catanzaro - Piper Sandler Joel Beatty - Citi Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Halozyme Third Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please begin. Al Kildani Good afternoon
For further details see:
Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q3 2020 Results - Earnings Call Transcript